# FDA approved Casgevy as the first CRISPR/Cas9 gene-editing therapy for sickle cell disease

Date: 2023

_No public text on this fact yet._

## Drivers

- Gene-Editing Diffusion: https://factrail.ai/drivers/gene-editing-diffusion

## Sources

_Sources are listed on the canonical page._

## Methodology

https://factrail.ai/methodology

Canonical: https://factrail.ai/facts/fda-casgevy-sickle-cell-crispr-therapy-approval-december-2023